Literature DB >> 3140372

Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis.

P Franchimont1, A Reuter, Y Vrindts-Gevaert, M Bastings, M Malaise, C Sondag, M C Frere, P Gysen.   

Abstract

Using radio-immunoassay methods, the production of tumour necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), and interferon-gamma (IFN-gamma) released by peripheral blood mononuclear cells (PBMC), maintained in culture and stimulated by phytohemagglutinin (PHA), was measured in normal subjects and patients with active or inactive rheumatoid arthritis (RA). Results indicated a dissociation between mitogenic response and secretion of mediators by PBMC under the influence of PHA in both normal controls and in patients with rheumatoid arthritis (RA). While [3H]thymidine incorporation was characterized by a rather bell-shaped curve with increasing concentrations of PHA, IL-2 and TNF-alpha displayed a linear dose-dependent increase. [3H]thymidine uptake by PBMC was in the same range in normal subjects as in patients with active and inactive RA, although cytokine secretion differed. The PBMC of patients with active RA produced less TNF-alpha, IL-2, and IFN-gamma than did those of the controls. In cases of inactive RA, the secretory response varied from subject to subject; mean values did not differ from those of normal subjects, except for those of IL-2 (p less than 0.01). The significance and the clinical relevance of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140372     DOI: 10.3109/03009748809098783

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  7 in total

1.  Cytokines in rheumatoid arthritis.

Authors:  P Kahle; J Saal; G Pawelec
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

2.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease.

Authors:  J A van Roon; C M Verhoef; J L van Roy; F H Gmelig-Meyling; O Huber-Bruning; F P Lafeber; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

4.  Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue.

Authors:  P Kahle; J G Saal; K Schaudt; J Zacher; P Fritz; G Pawelec
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

5.  Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity.

Authors:  G T Espersen; M Vestergaard; E Ernst; N Grunnet
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

6.  Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro.

Authors:  A Mackiewicz; M Sobieska; M Kapciñska; S H Mackiewicz; K E Wiktorowicz; T Pawłowski
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

7.  In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.

Authors:  S Matsubayashi; F Akasu; Y Kasuga; K Snow; E Keystone; R Volpé
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.